Data protection Impressum

Digital Health

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (June 2026)

29 June 2026

Geneva-based medtech company ABCDx has reached several milestones with LVOCheck, its point-of-care platform for diagnosing large vessel occlusion stroke, including a peer-reviewed publication, the completion of a Eurostars project and the start of its industrialization.

Geneva’s ABCDx reaches several milestones with its acute stroke diagnostics platform

29 June 2026

LEM Surgical, a Bern-based developer of robotic technologies for hard tissue surgery, has received a second FDA 510(k) clearance for its Dynamis Robotic Surgical System, adding new capabilities for spine surgery.

Bern-based LEM Surgical secures second FDA clearance for its Dynamis surgical robot

24 June 2026

The Foundation for Innovation and Technology has awarded CHF 100,000 Tech Seed loans to Detectra, TUUS Solutions and Anyway Systems, supporting innovations in arthritis monitoring, nutrient delivery and sovereign AI infrastructure.

FIT grants Tech Seed loans to three innovative Vaud start-ups

22 June 2026

SOPHiA GENETICS, the Lausanne-based leader in AI-driven precision medicine, has closed an oversubscribed public offering with gross proceeds of USD 57.5 million to expand its platform, applications and partnerships.

SOPHiA GENETICS raises USD 57.5 million in oversubscribed public offering

22 June 2026

Impli, the deeptech company developing continuous molecular monitoring for hormonal health and present at Biopôle in Lausanne, has been awarded a GBP 1.4 million grant to bring its hormone-monitoring patch toward clinical validation for in vitro fertilization.

Impli secures GBP 1.4 million grant to advance continuous hormone monitoring for IVF

16 June 2026

Geneva-based femtech start-up TrialHer has converted early demand into paid pilots with two companies in the UK and Europe, and was selected to join the WHO/Europe Public Health Innovation Platform.

Geneva femtech TrialHer secures first paid pilots and WHO selection

15 June 2026

Geneva-based MindMaze Therapeutics announced a CHF 8 million strategic equity financing from Neuro.io Group, funding the expansion of its U.S. commercial operations and opening the door to a potential combination of neurotherapeutics and artificial intelligence.

MindMaze secures CHF 8 million to expand its neurotherapeutics platform

1 June 2026

Two Vaud start-ups receive SDSC backing for AI projects, as Neurosoft gains access to the Alps supercomputer for neural AI training.

Western Switzerland steps up support for AI-driven innovation

18 May 2026

Three Geneva-based start-ups have received seed funding through the FONGIT Innovation Fund (FIF), supporting innovations in olfactory diagnostics, AI-powered maritime chartering, and SME cybersecurity.

Geneva backs three start-ups tackling smell, shipping, and cyber threats

27 April 2026

1 2 3 4 5 6 … 14